HIV prevalence — all countries

HIV prevalence — Europe & Central Asia

HIV prevalence in Europe & Central Asia in 2022 — 0.23%. Since 2016, the indicator has fallen by 0 pp.

2022 0.23% +0 pp vs 2021
World rank
Period maximum 0.23%2017
Period minimum 0.22%2018

Trend over time

2016–2022 · % of population aged 15–49

HIV prevalence — Europe & Central Asia, 2016–20220.220.220.230.230.2320162017201820192020202120222016: 0.23%2017: 0.23%2018: 0.22%2019: 0.22%2020: 0.22%2021: 0.22%2022: 0.23%
Change over the period: −0 pp Annual average: 0 pp

Comparison, 2022

How the value compares with the world and the groups this territory belongs to: Europe & Central Asia

Europe & Central Asia 0.23%
World 0.7%
HIV prevalence — Europe & Central Asia, by year Europe & Central Asia All countries CSV XLSX
Year % Change, pp
2022 0.23 +0 pp
2021 0.22 +0 pp
2020 0.22 +0 pp
2019 0.22 +0 pp
2018 0.22 −0.01 pp
2017 0.23 +0 pp
2016 0.23

About the indicator

The share of the population aged 15–49 living with HIV, as estimated by UNAIDS. The age range is chosen as the period of greatest sexual activity. In several countries of Southern Africa the indicator exceeds 15%, which makes HIV a key factor limiting life expectancy in the region.

Source: Global Health Observatory (WHO), license CC BY-NC-SA 3.0 IGO.